Objective: To investigate the morbidity of metabolic syndrome (MS) in endometrial cancers patients (EC) and explore the relationship between endometrial cancers and metabolic syndrome.
Methods: 50 cases of endometrial cancers were enrolled as study group, 100 cases of uterine fibroids were enrolled as control group. Clinical characteristics of the two groups were compared. Morbidity of metabolic syndrome in both groups was calculated. Minitab version17 software was used for statistical analysis
Results: Compared with the control group, systolic blood pressure, diastolic blood pressure, body mass index (BMI), abdominal circumference, the fasting blood glucose, fasting blood insulin, plasma triglycerides, morbidity of metabolic syndrome (47.50% vs. 19.25%) in study group were significantly increased (all P<0.05). The level of high-density lipoprotein cholesterol in study group was lower than it in control group (P<0.05).
Conclusion: The morbidity of MS in endometrial cancers patients is higher.